Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV

Bai, 2020, Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials, J. Neurol. Neurosurg. Psychiatry, 91, 21, 10.1136/jnnp-2019-320912 Bing, 2001, Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States, Arch. Gen. Psychiatr., 58, 721, 10.1001/archpsyc.58.8.721 Cassol, 2015, Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression, J. Acquir. Immune Defic. Syndr., 69, 18, 10.1097/QAI.0000000000000551 Castillo-Mancilla, 2022, High residual inflammation despite HIV viral suppression: lessons learned from real‐time adherence monitoring among people with HIV in Africa, HIV Med., 23, 465, 10.1111/hiv.13200 Cho, 2019, Transcriptomic predictors of inflammation-induced depressed mood, Neuropsychopharmacology, 44, 923, 10.1038/s41386-019-0316-9 Cruess, 2003, Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease, Biol. Psychiatr., 54, 307, 10.1016/S0006-3223(03)00318-4 Curzytek, 2021, Targeting the CCL2-CCR2 axis in depressive disorders, Pharmacol. Rep., 73, 1052, 10.1007/s43440-021-00280-w Deeks, 2011, HIV infection, inflammation, immunosenescence, and aging, Annu. Rev. Med., 62, 141, 10.1146/annurev-med-042909-093756 Eid, 2019, Sex differences in depression: insights from clinical and preclinical studies, Prog. Neurobiol., 176, 86, 10.1016/j.pneurobio.2019.01.006 Ellis, 2021, Social isolation is linked to inflammation in aging people with HIV and uninfected individuals, J. Acquir. Immune Defic. Syndr., 86, 600, 10.1097/QAI.0000000000002596 Ellis, 2020, Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV, Brain Behav. Immun. Health, 7 Fonseka, 2015, Novel investigational drugs targeting IL-6 signaling for the treatment of depression, Expet Opin. Invest. Drugs, 24, 459, 10.1517/13543784.2014.998334 Fumaz, 2012, Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment, Brain Behav. Immun., 26, 568, 10.1016/j.bbi.2012.01.001 Gimeno, 2009, Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study, Psychol. Med., 39, 413, 10.1017/S0033291708003723 Gokhale, 2019, Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009-2014, AIDS Behav., 23, 3452, 10.1007/s10461-019-02613-6 Gonzalez, 2011, Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis, J. Acquir. Immune Defic. Syndr., 58, 181, 10.1097/QAI.0B013E31822D490A Gubbels Bupp, 2015, Sex, the aging immune system, and chronic disease, Cell. Immunol., 294, 102, 10.1016/j.cellimm.2015.02.002 Haroon, 2018, Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder, Psychoneuroendocrinology, 95, 43, 10.1016/j.psyneuen.2018.05.026 Harrison, 2009, Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity, Biol. Psychiatr., 66, 407, 10.1016/j.biopsych.2009.03.015 Heaton, 2010, HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study, Neurology, 75, 2087, 10.1212/WNL.0b013e318200d727 Heaton, 1995, The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center, J. Int. Neuropsychol. Soc., 1, 231, 10.1017/S1355617700000230 Hellmuth, 2017, Depression and anxiety are common in acute HIV infection and associate with plasma immune activation, AIDS Behav., 21, 3238, 10.1007/s10461-017-1788-4 Howren, 2009, Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis, Psychosom. Med., 71, 171, 10.1097/PSY.0b013e3181907c1b Huang, 2019, Longitudinal association of inflammation with depressive symptoms: a 7-year cross-lagged twin difference study, Brain Behav. Immun., 75, 200, 10.1016/j.bbi.2018.10.007 Ironson, 2017, Depression and survival in a 17-year longitudinal study of people with HIV: moderating effects of race and education, Psychosom. Med., 79, 749, 10.1097/PSY.0000000000000488 Irwin, 2019, Moderators for depressed mood and systemic and transcriptional inflammatory responses: a randomized controlled trial of endotoxin, Neuropsychopharmacology, 44, 635, 10.1038/s41386-018-0259-6 Jia, 2004, Health-related quality of life among men with HIV infection: effects of social support, coping, and depression, AIDS Patient Care STDS, 18, 594, 10.1089/apc.2004.18.594 Kappelmann, 2018, Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions, Mol. Psychiatr., 23, 335, 10.1038/mp.2016.167 Kelly, 2021, Depression and interleukin-6 signaling: a mendelian randomization study, Brain Behav. Immun., 95, 106, 10.1016/j.bbi.2021.02.019 Kruse, 2021, Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression, J. Psychiatr. Res., 140, 350, 10.1016/j.jpsychires.2021.06.009 Kruse, 2021, Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers, Transl. Psychiatry, 11, 167, 10.1038/s41398-021-01268-z Lu, 2019, Inflammation and risk of depression in HIV: prospective findings from the multicenter AIDS cohort study, Am. J. Epidemiol., 188, 1994, 10.1093/aje/kwz190 McIntosh, 2018, Resting-state connectivity and spontaneous activity of ventromedial prefrontal cortex predict depressive symptomology and peripheral inflammation in HIV, J. Neurovirol., 24, 616, 10.1007/s13365-018-0658-9 Memiah, 2021, Mental health symptoms and inflammatory markers among HIV infected patients in Tanzania, BMC Publ. Health, 21, 1113, 10.1186/s12889-021-11064-5 Miller, 2016, The role of inflammation in depression: from evolutionary imperative to modern treatment target, Nat. Rev. Immunol., 16, 22, 10.1038/nri.2015.5 Morgello, 2001, The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease, Neuropathol. Appl. Neurobiol., 27, 326, 10.1046/j.0305-1846.2001.00334.x Musinguzi, 2018, Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda, BMC Immunol., 19, 1, 10.1186/s12865-017-0239-3 Nanni, 2015, Depression in HIV infected patients: a review, Curr. Psychiatr. Rep., 17, 530, 10.1007/s11920-014-0530-4 Norcini Pala, 2016, Subtypes of depressive symptoms and inflammatory biomarkers: an exploratory study on a sample of HIV-positive patients, Brain Behav. Immun., 56, 105, 10.1016/j.bbi.2016.02.013 Orlando, 2002, Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study, Int. J. Methods Psychiatr. Res., 11, 75, 10.1002/mpr.125 Osimo, 2020, Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls, Brain Behav. Immun., 87, 901, 10.1016/j.bbi.2020.02.010 Pala, 2016, Subtypes of depressive symptoms and inflammatory biomarkers: an exploratory study on a sample of HIV-positive patients, Brain Behav. Immun., 56, 105, 10.1016/j.bbi.2016.02.013 Poudel-Tandukar, 2014, C-Reactive protein and depression in persons with human immunodeficiency virus infection: the positive living with HIV (POLH) study, Brain Behav. Immun., 42, 89, 10.1016/j.bbi.2014.06.004 Power, 2008, Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins, Br. J. Nutr., 99, 931, 10.1017/S0007114507853347 Ragin, 2006, Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection, Neurology, 66, 1255, 10.1212/01.wnl.0000208433.34723.65 Raison, 2013, A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers, JAMA Psychiatr., 70, 31, 10.1001/2013.jamapsychiatry.4 Rivera-Rivera, 2014, Depression correlates with increased plasma levels of inflammatory cytokines and a dysregulated oxidant/antioxidant balance in HIV-1-Infected subjects undergoing antiretroviral therapy, J. Clin. Cell. Immunol., 5 Ruggieri, 2016, The influence of sex and gender on immunity, infection and vaccination, Annali dell'Istituto superiore di sanita, 52, 198 Saylor, 2019, Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naive adults in Rakai, Uganda, J. Neurovirol., 25, 735, 10.1007/s13365-019-00759-6 Schmiedel, 2018, Impact of genetic polymorphisms on human immune cell gene expression, Cell, 175, 1701, 10.1016/j.cell.2018.10.022 Slusarczyk, 2016, A potential contribution of chemokine network dysfunction to the depressive disorders, Curr. Neuropharmacol., 14, 705, 10.2174/1570159X14666160219131357 Stewart, 2020, Associations of total, cognitive/affective, and somatic depressive symptoms and antidepressant use with cardiovascular disease-relevant biomarkers in HIV: veterans aging cohort study, Psychosom. Med., 82, 461, 10.1097/PSY.0000000000000808 Tang, 2022, Gene expression analysis of CCL2, MOBP and OPALIN in major depressive disorder and suicidality, Neurology, 98, 3266, 10.1212/WNL.98.18_supplement.3266 Tate, 2003, The impact of apathy and depression on quality of life in patients infected with HIV, AIDS Patient Care STDS, 17, 115, 10.1089/108729103763807936 Tenorio, 2014, Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment, J. Infect. Dis., 210, 1248, 10.1093/infdis/jiu254 Valkanova, 2013, CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies, J. Affect. Disord., 150, 736, 10.1016/j.jad.2013.06.004 Vogelzangs, 2012, Association of depressive disorders, depression characteristics and antidepressant medication with inflammation, Transl. Psychiatry, 2, e79, 10.1038/tp.2012.8 Wittchen, 1991, Cross-cultural feasibility, reliability and sources of variance of the composite international diagnostic Interview (CIDI). The multicentre WHO/ADAMHA field trials, Br. J. Psychiatry, 159, 645, 10.1192/bjp.159.5.645 Wium-Andersen, 2013, Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals, JAMA Psychiatr., 70, 176, 10.1001/2013.jamapsychiatry.102 Wong, 2008, Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response, Mol. Psychiatr., 13, 800, 10.1038/mp.2008.59 Yang, 2015, Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression, Biol. Psychiatr., 77, e19, 10.1016/j.biopsych.2014.06.021 Young, 2014, A review of the relationship between proinflammatory cytokines and major depressive disorder, J. Affect. Disord., 169, 15, 10.1016/j.jad.2014.07.032